Price competition is not a major factor in the UK prescription pharma market, according to a Department of Health report.The …
Hospitals built under the private finance initiative are suffering from financial problems, bed shortages and poor design, according to a …
Galen faces a legal challenge in the US over the patent rights to a product it bought only last month.The …
Schering-Plough has admitted that it underestimated the effect that Claritin switching to an over-the-counter product would have on its profits.The …
Deep divisions within the Labour party over foundation hospitals have been further exposed in the House of Commons.More than 100 …
AstraZeneca will work exclusively with Publicis and WPP agencies in the US following a rationalisation of its advertising partnerships.The review, …
The world's largest pension fund has urged GlaxoSmithKline to step up its efforts to help combat the AIDS pandemic in …
The long awaited diabetes national service framework has been launched with demanding new targets for the improvement of NHS services.By …
Kelly Martin, a former senior executive at Merrill Lynch, has been named chief executive of troubled Irish pharmaceutical company Elan.The …
European industry body EFPIA is seeking legal action against the Italian Government new reimbursement and pricing policy, which it believes …
A row over patents on diabetes and asthma drugs has produced a deadlock in talks to improve access to medicines …
Current Pharmacia Chief Executive Fred Hassan has been tipped to take over the top job at Schering-Plough once the Pfizer/Pharmacia …
Leading diabetes specialist Dr Sue Roberts has been appointed as the new National Clinical Director for Diabetes, and will oversee …
Roche has recorded a $2.8 billion net loss for 2002 after writing off CHF9 billion costs following its embarrassing exit …